Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.
about
GADD45 proteins: central players in tumorigenesisRepurposing Drugs in Oncology (ReDO)-mebendazole as an anti-cancer agentNon-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian cancer cellsIKK inhibition increases bortezomib effectiveness in ovarian cancer.Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentDeacetylation by SIRT1 Reprograms Inflammation and CancerProteasome inhibition increases recruitment of IκB kinase β (IKKβ), S536P-p65, and transcription factor EGR1 to interleukin-8 (IL-8) promoter, resulting in increased IL-8 production in ovarian cancer cells.Perspectives of pharmacological treatment in otosclerosis.Diethylcarbamazine: possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice.Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt/β-catenin/Tcf signaling pathway in human glioblastoma cells.NSAIDs induce apoptosis in nonproliferating ovarian cancer cells and inhibit tumor growth in vivo.Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment.Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agentLicochalcone A-induced human bladder cancer T24 cells apoptosis triggered by mitochondria dysfunction and endoplasmic reticulum stressThe efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma.Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.Proteasomal Dysfunction Induced By Diclofenac Engenders Apoptosis Through Mitochondrial Pathway.
P2860
Q24608649-FC1BF1F3-EBD2-41B8-956E-1EEC53C0E189Q33893928-762E0453-386E-40B3-9D4D-E5A238A46818Q34700681-5429389F-C2C0-457D-ACA6-6508182674C7Q36413454-DB1A0F6C-9D28-4FCF-843C-871DE2539EFEQ36483712-77494657-FC46-45A4-AE8A-6BB7B5F06065Q37150502-6D3C8793-3B46-401E-84BF-2A871A7D4E48Q37536497-59D90E94-FDD7-441F-A47B-8A826FF07F93Q38030443-D001DDA3-18EB-4635-B90B-5818D5BC1642Q39039913-88650163-834E-4A82-9069-0EAD0E9422B8Q39098613-99617E2E-8645-4910-A5D4-200971358A4CQ39350226-1B220E7A-EB69-4DA1-8944-1AA292D927EBQ39390630-BB945347-6429-4EE3-B3FF-EC08DF85481CQ41668110-99E020D4-E0FA-4307-A2E8-46652F4CF053Q42143708-63BE646D-B7B2-4A4B-A128-160F99E002FBQ42279694-9B1E0CB0-9356-43D8-BD41-0C990B5FAD44Q46690739-508DC20B-AC21-4C3D-B26A-189A2666FED2Q51597152-95E284DF-283A-41F1-9160-926A3F5AB94C
P2860
Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Combinatorial effect of non-st ...... ors in ovarian cancer therapy.
@ast
Combinatorial effect of non-st ...... ors in ovarian cancer therapy.
@en
Combinatorial effect of non-st ...... ors in ovarian cancer therapy.
@nl
type
label
Combinatorial effect of non-st ...... ors in ovarian cancer therapy.
@ast
Combinatorial effect of non-st ...... ors in ovarian cancer therapy.
@en
Combinatorial effect of non-st ...... ors in ovarian cancer therapy.
@nl
prefLabel
Combinatorial effect of non-st ...... ors in ovarian cancer therapy.
@ast
Combinatorial effect of non-st ...... ors in ovarian cancer therapy.
@en
Combinatorial effect of non-st ...... ors in ovarian cancer therapy.
@nl
P2093
P2860
P50
P1433
P1476
Combinatorial effect of non-st ...... ors in ovarian cancer therapy.
@en
P2093
Akos Czibere
Devanand Sarkar
Jason Cordeiro
Jin-Rong Zhou
Linglin Li
Luiz F Zerbini
Paul B Fisher
Ricardo G Correa
Xuesong Gu
Yihong Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0024285
P407
P577
2011-09-12T00:00:00Z